Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer

Immunohistochemistry (IHC) has become an indispensable tool in the clinical practices for breast cancer; however, to achieve its standardization, numerous issues need to be overcome. In this review, we describe the development of IHC as an important clinical tool, and the challenges in standardizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Shinobu, Nakanishi, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAPAN SOCIETY OF HISTOCHEMISTRY AND CYTOCHEMISTRY 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986307/
https://www.ncbi.nlm.nih.gov/pubmed/36890849
http://dx.doi.org/10.1267/ahc.22-00050
Descripción
Sumario:Immunohistochemistry (IHC) has become an indispensable tool in the clinical practices for breast cancer; however, to achieve its standardization, numerous issues need to be overcome. In this review, we describe the development of IHC as an important clinical tool, and the challenges in standardizing IHC results for patients. We also present ideas for resolving the remaining issues and unmet needs, along with future directions.

Ejemplares similares